Longitudinal Trajectories of the Cognitive Function Index in the A4 Study

Authors:

Abstract
The Anti-Amyloid in Asymptomatic Alzheimer’s Disease (A4) Study failed to show a treatment benefit with solanezumab, but the longitudinal consequence

This publication has 20 references indexed in Scilit: